Osteoarthritis market forecast

DelveInsight’s Osteoarthritis Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM.

NEVADA, LAS VEGAS, UNITED STATES, March 29, 2024 /EINPresswire.com/ -- The Osteoarthritis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteoarthritis pipeline products will significantly revolutionize the Osteoarthritis market dynamics.

DelveInsight’s “Osteoarthritis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Osteoarthritis, historical and forecasted epidemiology as well as the Osteoarthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Osteoarthritis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

To Know in detail about the Osteoarthritis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Osteoarthritis Market Insights

Some of the key facts of the Osteoarthritis Market Report:
The Osteoarthritis market size was valued approximately USD 18,690 million in the United States among the 7MM countries in 2022 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
The Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study in Japan conducted by Yoshimura, showed a significant rise in knee OA through working age. As per this study, in Japan, OA affects approximately 25.3 million individuals aged over 40 years
The study by Swain et al., aimed to explore the incidence and prevalence of OA in the UK in 2017 and their trends using the UK Clinical Practice Research Data link (CPRD) comprising data on nearly 17.5 million patients
Key Osteoarthritis Companies: Centrexion Therapeutics, Taiwan Liposome Company, Grünenthal, Biosplice Therapeutics, Techfields, MiMedx, Ampio Pharmaceuticals, Organogenesis, Medipost, Naturecell, and others
Key Osteoarthritis Therapies: CNTX-4975, TLC599, Resiniferatoxin, RTX-GRT7039, Lorecivivint, X0002, Amniofix, Ampion, ReNu, Cartistem, JointStem, and others

Osteoarthritis Overview
Osteoarthritis (OA), also known as degenerative joint disease (DJD), is the most common type of arthritis, affecting millions of people worldwide. It occurs when the protective cartilage that cushions the ends of the bones wears down over time. Although osteoarthritis can damage any joint in the body, the disorder most commonly affects joints in hands, knees, hips and spine, and is more likely to develop as people age although it can occur in adults of any age.

Get a Free sample for the Osteoarthritis Market Report -
https://www.delveinsight.com/report-store/osteoarthritis-market?utm_source=einpresswire&utm_medium=pressrelease&utm_campaign=gpr

Osteoarthritis Market
The dynamics of the Osteoarthritis market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.
“According to the estimates, the highest market size of OA was found in the United States and the least was in Italy across the 7MM. Besides, the upcoming therapies of OA are expected to combat the current unmet needs faced by the patients with OA and add to the overall growth of the OA market size.”

Osteoarthritis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Osteoarthritis Epidemiology Segmentation:
The Osteoarthritis market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
Total Prevalence of Osteoarthritis
Prevalent Cases of Osteoarthritis by severity
Gender-specific Prevalence of Osteoarthritis
Diagnosed Cases of Episodic and Chronic Osteoarthritis

Download the report to understand which factors are driving Osteoarthritis epidemiology trends @ Osteoarthritis Epidemiological Insights

Osteoarthritis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Osteoarthritis market or expected to get launched during the study period. The analysis covers Osteoarthritis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Osteoarthritis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Osteoarthritis Therapies and Key Companies
CNTX-4975: Centrexion Therapeutics
TLC599: Taiwan Liposome Company
Resiniferatoxin/RTX-GRT7039: Grünenthal
Lorecivivint: Biosplice Therapeutics
X0002: Techfields
Amniofix: MiMedx
Ampion: Ampio Pharmaceuticals
ReNu: Organogenesis
Cartistem: Medipost
JointStem: Naturecell

Osteoarthritis Market Strengths
Now companies are investing heavily in developing disease modifying therapies for the treatment of Osteoarthritis which will fulfill a major unmet need
Single injection joint function enhancing hyaluronic acid formulation’s sales are steadily rising, and companies are looking to expand into new markets in order to increase their profit of their single injection products

Osteoarthritis Market Opportunities
Lucrative opportunities in nations where single-injection joint function enhancing drugs are unavailable. The growth of the Osteoarthritis market is driven by an increase in the geriatric population and obesity

Scope of the Osteoarthritis Market Report
Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Osteoarthritis Companies: Centrexion Therapeutics, Taiwan Liposome Company, Grünenthal, Biosplice Therapeutics, Techfields, MiMedx, Ampio Pharmaceuticals, Organogenesis, Medipost, Naturecell, and others
Key Osteoarthritis Therapies: CNTX-4975, TLC599, Resiniferatoxin, RTX-GRT7039, Lorecivivint, X0002, Amniofix, Ampion, ReNu, Cartistem, JointStem, and others
Osteoarthritis Therapeutic Assessment: Osteoarthritis current marketed and Osteoarthritis emerging therapies
Osteoarthritis Market Dynamics: Osteoarthritis market drivers and Osteoarthritis market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Osteoarthritis Unmet Needs, KOL’s views, Analyst’s views, Osteoarthritis Market Access and Reimbursement

Discover more about therapies set to grab major Osteoarthritis market share @ Osteoarthritis market forecast

Table of Contents
1. Osteoarthritis Market Report Introduction
2. Executive Summary for Osteoarthritis
3. SWOT analysis of Osteoarthritis
4. Osteoarthritis Patient Share (%) Overview at a Glance
5. Osteoarthritis Market Overview at a Glance
6. Osteoarthritis Disease Background and Overview
7. Osteoarthritis Epidemiology and Patient Population
8. Country-Specific Patient Population of Osteoarthritis
9. Osteoarthritis Current Treatment and Medical Practices
10. Osteoarthritis Unmet Needs
11. Osteoarthritis Emerging Therapies
12. Osteoarthritis Market Outlook
13. Country-Wise Osteoarthritis Market Analysis (2019–2032)
14. Osteoarthritis Market Access and Reimbursement of Therapies
15. Osteoarthritis Market Drivers
16. Osteoarthritis Market Barriers
17. Osteoarthritis Appendix
18. Osteoarthritis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Gaurav Bora
DelveInsight Business Research
+1 469-945-7679
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.